Merck KGaA has shed more light on the failure of its lupus drug in one cohort of patients, while pointing to secondary ...

Germany’s Merck KGaA has presented detailed results from cohort B of the global Phase II WILLOW study of enpatoran, an ...

Hoping to gain an edge in the rapidly growing market are MilliporeSigma and Simtra BioPharma Solutions, which have forged a ...

Benchling announced a new collaboration with Merck, known as MSD outside of the United States and Canada, to implement a ...

NMPA’s Center for Drug Evaluation accepted Merck KGaA’s application for marketing authorization of pimicotinib as a Class 1 ...

Barreling toward the loss of exclusivity on its blockbuster oncology therapy Keytruda, Merck & Co. has reportedly offered $3 ...

Merck has received approval from the Food and Drug Administration to expand use of its blockbuster drug, Keytruda, to treat ...

The Food and Drug Administration has approved a new drug from Merck designed to protect infants from respiratory syncytial ...